// App-Quantinova.ai

3630 : Impact Of Thrombin Generation, Tissue Factor Activity and Thrombomodulin Activity On The Positivity Of Assisted Reproductive Technique In Infertile Women

Researchers

Presenter

  • Emmanuelle Mathieu -Argent

Principal Investigators

  • Patrick Van Dreden

  • Marjorie Comtet

  • Grigoris T Gerotziafas

  • Vassiliki Galea

  • Hela Ketatni

  • Matthieu Grusse

  • Jean-Marie Antoine

  • Severine Bouffard

  • Aurelie Rousseau

  • Elmina Lefkou

  • Ismail Elalamy

Medical Centers

  • 1 INSERM U938, Faculte de Medecine Pierre et Marie Curie, Universite Paris VI, Paris, France

  • Research and Development, Diagnostica Stago, Gennevilliers, France

  • Service -Hematologie Biologique, Hopital Tenon Assistance Publique Hopitaux de Paris, France, Paris, France

  • Department of Obstetrics and Gynecology, Hopital Tenon, Assistance Publique Hopitaux de Paris., Paris, France

  • ERUPMC Faculte de medecin pierre et marie curie, Paris, France

  • Department of Obstetrics and Gynecology, Hopital Tenon, Assistance Publique Hopitaux de Paris., Paris, France

  • 1 INSERM U938, Faculte de Medecine Pierre et Marie Curie, Universite Paris VI, Paris, France

  • ERUPMC Faculte de medecin pierre et marie curie, Paris, France

  • Service dHematologie Biologique Hopital Tenon, Hopitaux Universitaires Est Parisien, Assistance Publique Hopitaux de Paris, Paris, France

  • Service -Hematologie Biologique, Hopital Tenon Assistance Publique Hopitaux de Paris, France, Paris, France

  • Diagnostica Stago, Gennevilliers, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Ovarian hyperstimulation syndrome

  • Venous thrombosis

Biomarkers

  • Coagulation Factor III, Tissue Factor

Drug/Treatment

  • Thrombomodulin alfa

  • Evithrom

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim